Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheron Latcha

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Journal of the American Society of Nephrology : CJASN|April 14, 2016
Long-Term Renal Outcomes after Cisplatin TreatmentSheron Latcha, Edgar A Jaimes, Sujata Patil, et al.
Journal of Pain and Symptom Management|February 5, 2020
"Please Keep Mom Alive One More Day"-Clashing Directives of a Dying Patient and Her SurrogateSheron Latcha, Camille Lineberry, Nikoletta Lendvai, et al.
The Lancet. Healthy Longevity|September 13, 2022
Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situationBen Sprangers, Annelien Van der Veen, Marije E Hamaker, et al.
Clinical Nephrology|November 1, 2019
Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells
Brianne N Dixon, Ryan J Daley, Larry W Buie, et al.
Kidney360|May 30, 2024
Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Coprescribed Serotonin Receptor Antagonists: A Retrospective AnalysisVictoria Gutgarts, Supriya Gerardine, Roman A Shingarev, et al.
JAMA Oncology|August 21, 2025
Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level DataRobert C Grant, Jiang Chen He, Ning Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice GuidelineAntonio Finelli, Nofisat Ismaila, Bill Bro, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Journal of the American Society of Nephrology : CJASN|April 14, 2016
Long-Term Renal Outcomes after Cisplatin TreatmentSheron Latcha, Edgar A Jaimes, Sujata Patil, et al.
Journal of Pain and Symptom Management|February 5, 2020
"Please Keep Mom Alive One More Day"-Clashing Directives of a Dying Patient and Her SurrogateSheron Latcha, Camille Lineberry, Nikoletta Lendvai, et al.
The Lancet. Healthy Longevity|September 13, 2022
Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situationBen Sprangers, Annelien Van der Veen, Marije E Hamaker, et al.
Clinical Nephrology|November 1, 2019
Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells
Brianne N Dixon, Ryan J Daley, Larry W Buie, et al.
Kidney360|May 30, 2024
Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Coprescribed Serotonin Receptor Antagonists: A Retrospective AnalysisVictoria Gutgarts, Supriya Gerardine, Roman A Shingarev, et al.
JAMA Oncology|August 21, 2025
Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level DataRobert C Grant, Jiang Chen He, Ning Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice GuidelineAntonio Finelli, Nofisat Ismaila, Bill Bro, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Pageof 3